The latter two were predicted to be higher in COPD EVs, while Rho GDP-dissociation inhibitor (RHOGDI) signaling was predicted to be lower in COPD EVs compared to healthy controls. This evidence concerns the gene ARHGDIA and chronic obstructive pulmonary disease.